Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Lu Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6807-2647; OpenAlex author ID A5019891864. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.chembiol.2022.07.002↗
  2. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Last author DOI 10.1073/pnas.1914557116↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiongxiong Lu · 2 shared papers, 2019–2022 · strength 0.19
  2. Xinjing Wang · 2 shared papers, 2019–2022 · strength 0.19
  3. Cai‐Guang Yang · 1 shared paper, 2022 · strength 0.13
  4. Pengyu Wang · 1 shared paper, 2022 · strength 0.13
  5. Yonghui Zhang · 1 shared paper, 2022 · strength 0.13
  6. Xiaomei Tang · 1 shared paper, 2019 · strength 0.06
  7. Yuan Fang · 1 shared paper, 2019 · strength 0.06
  8. Qian Zhan · 1 shared paper, 2019 · strength 0.06
  9. Min Li · 1 shared paper, 2019 · strength 0.06
  10. Chenghong Peng · 1 shared paper, 2019 · strength 0.06
  11. Chenlei Wen · 1 shared paper, 2019 · strength 0.06
  12. Baiyong Shen · 1 shared paper, 2019 · strength 0.06
  13. Qingbing Wang · 1 shared paper, 2019 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.